The small 11kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells

Blood

Volumn 115, Issue 5, 2010, Pages 1070-1080

  Chen, Aaron Yun ^a   Zhang, Elizabeth Yan ^a   Guan, Wuxiang ^a   Cheng, Fang ^a   Kleiboeker, Steve ^b   Yankee, Thomas M ^a   Qiu, Jianming ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ViraCor Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CASPASE 10; MESSENGER RNA; NONSTRUCTUCTURAL PARVOVIRUS B19 PROTEIN; NONSTRUCTURAL PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYSTEINE PROTEINASE INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; QUINOLINE DERIVATIVE; QUINOLINE VAL ASP(OME) CH2 OPH; QUINOLINE-VAL-ASP(OME)-CH2-OPH;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOPLASM; ERYTHEMA INFECTIOSUM; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; CELL CULTURE; CELL LINE; CELL STRAIN K 562; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; FLOW CYTOMETRY; GENETICS; HELA CELL; HOST PATHOGEN INTERACTION; HUMAN PARVOVIRUS B19; IMMUNOBLOTTING; METABOLISM; MOLECULAR WEIGHT; NICK END LABELING; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASE 10; CELL LINE; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; ERYTHROID PRECURSOR CELLS; FLOW CYTOMETRY; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; K562 CELLS; MOLECULAR WEIGHT; PARVOVIRUS B19, HUMAN; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77649200609     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-215756     Document Type: Article

References (48)

1. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350(6):586-597.
2. Tattersall P. The evolution of parvovirus taxonomy. In: Kerr J, Cotmore SF, Bloom ME, Linden RM, Parrish CR, eds. Parvoviruses. London, United Kingdom: Hodder Arond; 2006;5-14.
3. Luo W, Astell CR. A novel protein encoded by small RNAs of parvovirus B19. Virology. 1993;195(2):448-455.
4. St Amand J, Astell CR. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology. 1993;192(1):121-131.
5. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol. 1998;72(4):3018-3028.
6. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol. 1988;62(8):2884-2889.
7. Raab U, Beckenlehner K, Lowin T, et al. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology. 2002;293(1):86-93.
8. Brown KE. The genus Erythrovirus. In: Kerr J, Cotmore SF, Bloom ME, Linden RM, Parrish CR, eds. Parvoviruses. London, United Kingdom: Hodder Arnold; 2005;25-45.
9. Zhi N, Mills IP, Lu J, et al. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol. 2006;80(12):5941-5950.
10. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood. 1987;70(2):384-391.
11. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986;233(4766):883-886.
12. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol. 1988;62(8):3059-3063.
13. Brown KE, Young N. Human parvovirus B19: Pathogenesis of disease. In: Anderson LJ, Young N, eds. Human Parvovirus B19. Vol 20. Basel, Switzerland: Karger; 1997;105-119.
14. Sol N, Le JJ, Vassias I, et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol. 1999;73(10):8762-8770.
15. Morita E, Tada K, Chisaka H, et al. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J Virol. 2001;75(16):7555-7563.
16. Chisaka H, Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol. 2003;13(6):347-359.
17. Qiu J, Handa A, Kirby M, Brown KE. The interaction of heparin sulfate and adeno-associated virus 2. Virology. 2000;269(1):137-147.
18. Guan W, Cheng F, Yoto Y, et al. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol. 2008;82(20):9951-9963.
19. Wong S, Zhi N, Filippone C, et al. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol. 2008;82(5):2470-2476.
20. National Center for Biotechnology Information. GenBank. http://www.ncbi.nlm.nih.gov/Genbank. Accessed November 18, 2009.
21. Guan W, Wong S, Zhi N, Qiu J. The genome of human parvovirus B19 virus can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol. 2009;83(18):9541-9553.
22. Sun Y, Chen AY, Cheng F, et al. Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol. 2009;83(8):3956-3967.
23. Qiu J, Pintel DJ. The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template. Mol Cell Biol. 2002;22(11):3639-3652.
24. Qiu J, Cheng F, Burger LR, Pintel D. The transcription profile of Aleutian Mink Disease Virus (AMDV) in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J Virol. 2006;80(2):654-662.
25. Qiu J, Cheng F, Pintel D. Molecular characterization of caprine adeno-associated virus (AAV-Go. 1) reveals striking similarity to human AAV5. Virology. 2006;356(1-2):208-216.
26. Mercille S, Massie B. Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnol Bioeng. 1999;63(5):529-543.
27. Tollefson AE, Toth K, Doronin K, et al. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol. 2001;75(19):8875-8887.
28. Hanayama R, Tanaka M, Miyasaka K, et al. Auto-immune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304(5674):1147-1150.
29. Zoli W, Ulivi P, Tesei A, et al. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines. Breast Cancer Res. 2005;7(5):R681-R689.
30. Keen J, Serghides L, Ayi K, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. (http://dx.doi.org/10.1371/journal.pmed.0040181). 2007;4(5):e181.
31. Strauss L, Bergmann C, Szczepanski MJ, et al. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. J Immunol. 2008;180(5):2967-2980.
32. Johnson NA, Boyle M, Bashashati A, et al. Diffuse large B cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood. 2009;113(16):3773-3780
33. Blachon S, Bellanger S, Demeret C, Thierry F. Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. J Biol Chem. 2005;280(43):36088-36098.
34. Pilotte J, Larocque D, Richard S. Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. Genes Dev. 2001;15(7):845-858.
35. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol. 2006;80(8):4114-4121.
36. Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta. 1999;1489(1):141-158.
37. Burrer R, Neuman BW, Ting JP, et al. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J Virol. 2007;81(11):5637-5648.
38. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis. 2003;8(4):345-352.
39. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53(17):3976-3985.
40. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994;371(6495):346-347.
41. Chen M,Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis. 2002;7(4):313-319.
42. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol. 2003;15(6):725-731.
43. Kischkel FC, Lawrence DA, Tinel A, et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem. 2001;276(49):46639-46646.
44. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A. 2001;98(24):13884-13888.
45. Krantz SB. Erythropoietin. Blood. 1991;77(3):419-434.
46. De MR, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93(3):796-803.
47. De MR, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 1999;401(6752):489-493.
48. Zhi N, Zadori Z, Brown KE, Tijssen P. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology. 2004;318(1):142-152.